Form 4: HCA Healthcare EVP and COO Jon M. Foster Reports Changes in Beneficial Ownership
SEC Form 4
Jon M. Foster, EVP and COO of HCA Healthcare, reports transactions involving common stock and stock appreciation rights.
Summary
- On May 15, 2024, Jon M. Foster, EVP and COO of HCA Healthcare, engaged in transactions involving HCA's common stock and stock appreciation rights.
- Foster acquired 11,955 shares of common stock at $69.58 and 27,510 shares at $81.96 through the exercise of stock appreciation rights.
- He also disposed of 21,258 shares at $326.96.
- Following these transactions, Foster directly owns 40,037 shares of common stock.
- Additionally, he indirectly owns 55,058 shares through the JMF Trust, 5,350 shares through his spouse, 48,958 shares through the LCF Trust, and 19,985 shares through the JMF Family Trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for executives at publicly traded companies like HCA Healthcare, similar to filings made by executives at Tenet Healthcare and Universal Health Services.
- The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring transparency in executive stock transactions across the healthcare industry.
Stakeholder Impact
- Shareholders are informed about the executive's transactions, providing insights into management's perspective on the company's stock.
- The filing ensures transparency and compliance with SEC regulations, maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| 2011-02-15 | Date of Limited Power of Attorney execution. |
| 2017-01-29 | Stock appreciation rights vested in four equal annual installments beginning on this date. |
| 2018-02-01 | Stock appreciation rights vested in four equal annual installments beginning on this date. |
| 2024-05-15 | Date of transaction involving common stock and stock appreciation rights. |
| 2024-05-17 | Date of signature by Attorney-in-Fact. |
| 2026-01-29 | Expiration date of Stock Appreciation Right. |
| 2027-02-01 | Expiration date of Stock Appreciation Right. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.